Clinical trials
Leukemia, Biphenotypic, Acute trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 3 |
| 2017 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Active, not recruiting | 5 |
| Recruiting | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 11 |
| National Cancer Institute (NCI) | 3 |
| Syndax Pharmaceuticals | 2 |
| Kura Oncology, Inc. | 1 |
| NCIC Clinical Trials Group | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
| PedAL BCU, LLC | 1 |
| Seattle Children's Hospital | 1 |
| University of British Columbia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Biphenotypic, Acute | 22 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 18 |
| Leukemia | 9 |
| Leukemia, Myeloid, Acute | 9 |
| Burkitt Lymphoma | 7 |
| Blast Crisis | 4 |
| Leukemia, Hairy Cell | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Leukemia, Myelomonocytic, Juvenile | 4 |
| Leukemia, Large Granular Lymphocytic | 3 |
Trials
Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.